Glucose‐lowering drugs and liver‐related outcomes among individuals with type 2 diabetes: A systematic review of longitudinal population‐based studies

Documenti analoghi

• Hepatobiliary effects and safety of tirzepatide: A systematic review and meta‐analysis
  di: A. B. M. Kamrul‐Hasan, et al.
  Pubblicazione: (2024)
• Impact of glucagon‐like peptide‐1 receptor agonism‐based therapies on limb outcomes in peripheral artery disease and type 2 diabetes: An updated systematic review and meta‐analysis
  di: Deep Dutta, et al.
  Pubblicazione: (2025)
• Associations of glycaemia‐related risk factors with dementia and cognitive decline in individuals with type 2 diabetes: A systematic review and meta‐analysis
  di: Mahtab Tabesh, et al.
  Pubblicazione: (2025)
• Educational outcomes and the role of comorbidity among adolescents with type 1‐diabetes in Denmark
  di: Anne Bonde Thorsted, et al.
  Pubblicazione: (2024)
• Improving glycaemic outcomes with subsidised access to diabetes technology in a young adult population with type 1 diabetes
  di: Andrew‐Hyun Lee, et al.
  Pubblicazione: (2026)